✦ LIBER ✦

Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial

✍ Scribed by Aimée R Kreimer; Paula González; Hormuzd A Katki; Carolina Porras; Mark Schiffman; Ana Cecilia Rodriguez; Diane Solomon; Silvia Jiménez; John T Schiller; Douglas R Lowy; Leen-Jan van Doorn; Linda Struijk; Wim Quint; Sabrina Chen; Sholom Wacholder; Allan Hildesheim; Rolando Herrero

Book ID: 117785754
Publisher: The Lancet
Year: 2011
Tongue: English
Weight: 154 KB
Volume: 12
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(11)70213-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of human papillomavirus (HPV)-1

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

✍ J Paavonen; P Naud; J Salmerón; CM Wheeler; S-N Chow; D Apter; H Kitchener; X Ca 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 303 KB

Sustained efficacy and immunogenicity of

Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women

✍ N. De Carvalho; J. Teixeira; C.M. Roteli-Martins; P. Naud; P. De Borba; T. Zahaf 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 535 KB

Cross-protective efficacy of HPV-16/18 A

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

✍ Cosette M Wheeler; Xavier Castellsagué; Suzanne M Garland; Anne Szarewski; Jorma 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 221 KB

Efficacy of a bivalent L1 virus-like par

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

✍ Diane M Harper; Eduardo L Franco; Cosette Wheeler; Daron G Ferris; David Jenkins 📂 Article 📅 2004 🏛 The Lancet 🌐 English ⚖ 185 KB

Efficacy of a prophylactic adjuvanted bi

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

✍ Jorma Paavonen; David Jenkins; F Xavier Bosch; Paulo Naud; Jorge Salmerón; Coset 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 151 KB

Sustained efficacy and immunogenicity of

Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6·4 years

📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 248 KB